Edition:
United Kingdom

Joshua Franklin

SoftBank seeks to avoid WeWork's liabilities with new investment -sources

19 Oct 2019

NEW YORK SoftBank Group Corp is attempting to become the majority owner of WeWork without assuming the onerous lease obligations of the U.S. office-space sharing firm, according to people familiar with the matter.

Exclusive: WeWork owner creates committee to decide on financing lifeline

17 Oct 2019

NEW YORK WeWork owner, The We Company, has formed a special board committee to consider proposals for a $5 billion financing lifeline from its largest shareholder SoftBank Group Corp and its main lender JPMorgan Chase & Co , four people familiar with the matter said on Wednesday.

Private market gives WeWork shares the cold shoulder

15 Oct 2019

NEW YORK Trading in shares of WeWork in the private over-the-counter (OTC) market has almost ground to a halt, underscoring a loss of investor confidence in the office-sharing company and providing further evidence of its recent huge loss in value.

SoftBank seeks control of WeWork through financing package: source

14 Oct 2019

SoftBank Group Corp. has prepared a financing package for WeWork Companies Inc that would give it control over the shared office space company, a person familiar with the matter said. | Video

SoftBank-backed Vir Biotechnology raises $143 million in U.S. IPO

11 Oct 2019

NEW YORK Vir Biotechnology priced its initial public offering (IPO) at $20 a share on Thursday, at the bottom end of expectations, the latest underwhelming investment performance for a stock held by SoftBank Group Corp's Vision Fund.

Germany's BioNTech raises $150 million in smaller-than-planned U.S. IPO amid market volatility

10 Oct 2019

German biotechnology firm BioNTech SE raised $150 million in its U.S. initial public offering (IPO) on Thursday, after selling fewer shares and at a lower price than originally planned, the latest company to struggle to debut in the stock market

REFILE-Germany's BioNTech lowers price for U.S. IPO amid market volatility

09 Oct 2019

Oct 9 German biotechnology firm BioNTech SE lowered the price range for its U.S. initial public offering (IPO) on Wednesday and said it would sell fewer shares, making it the latest company to struggle to debut in the stock market.

Goldman evaluating role in China's Megvii IPO after U.S. blacklist

09 Oct 2019

NEW YORK/HONG KONG Goldman Sachs Group Inc said on Tuesday it was reviewing its involvement in Megvii Technology Ltd's planned initial public offering after the U.S. government placed the Chinese artificial intelligence firm on a human rights blacklist.

World News